Publications
-
Publication Reference Year Symeres Authors Customer Silicon-based Linkers for Tunable Acid-Sensitive Drug Release from Polymeric Nanoparticles Chemistry Europe. 2024 Dec 11:e202403589 2024 Tommi Meulemans and Peter Schuckman Cristal Therapeutics -
Publication Reference Year Symeres Authors Customer Rare Case of Polymorphism in the Binary System of Enantiomers of a Praziquantel Derivative Org. Process Res. Dev. 2024, 28, 4, 1224–1232 2024 Michel Leeman University of Rouen -
Publication Reference Year Symeres Authors Customer Towards Multitargeted Ligands as Pain Therapeutics: Dual Ligands of the Cavα2δ-1 Subunit of Voltage-Gated Calcium Channel and the μ-Opioid Receptor ChemMedChem 2024, e202300473 2024 Anita Wegert, Wouter de Graaf, Frank van Holst, Giovanni Bolcato WeLab Barcelona -
Publication Reference Year Symeres Authors Customer High Target Homology Does Not Guarantee Inhibition: Aminothiazoles Emerge as Inhibitors of Plasmodium falciparum ACS Infect. Dis. 2024, XXXX, XXX, XXX-XXX 2024 Melloney Dröge, Bernard van Vliet, Jack den Hartog -
Publication Reference Year Symeres Authors Customer Development of Potent Mcl-1 Inhibitors: Structural Investigations on Macrocycles Originating from a DNA-Encoded Chemical Library Screen J. Med. Chem. 2024 (67), 3039-3065 2024 Koen Hekking, Marjon Bolster, Sergio Maroto, Kees van Kekem, Frank Haasjes, Jack Slootweg, Patrick Oude Alink, Ron Dirks, Brian Kuijpers, Robin Doodeman, Dennis Smith -
Publication Reference Year Symeres Authors Customer Specific N-terminal attachment of TMTHSI linkers to native peptides and proteins for strain-promoted azide alkyne cycloaddition Chem. Commun., 2023, Advance Article 2023 Niels Hauwert Cristal Therapeutics -
Publication Reference Year Symeres Authors Customer Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate J. Med. Chem. 2023, 66, 23, 15648–15670 2023 Sander Brugman, Edwin Aret, Jan Sadownik, Eva Verhofstad and Dennis Sleegers Perha Pharmaceuticals -
Publication Reference Year Symeres Authors Customer Contemporary Chiral Resolutions Chim. Oggi., 2023, 41 (2) 2023 Michel Leeman -
Publication Reference Year Symeres Authors Customer Comparative biochemical kinase activity analysis identifies rivoceranibas a highly selective VEGFR2 inhibitor (Oncolines) Cancer Chemother Pharmacol., 2023 (6), 491-499 2023 Jeffrey Kooijman, Janneke Melis, Guido Zaman Elvar Therapeutics -
Publication Reference Year Symeres Authors Customer DT-0111: a novel P2X3 receptor antagonist (Organix) Purinergic Signalling, 2023 2023 Anu Mahadevan Danmir Therapeutics LLC
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.
